Posts Tagged ‘GSK’

RSS

May 13th, 2014

A Second Darapladib Phase 3 Trial Misses Its Endpoint

GSK said today that a large phase 3 trial of a once highly promising drug had failed to meet its primary endpoint. Last year the company announced that another phase 3 trial with the same drug had failed. GSK said it would “further analyse the data and better understand the findings” but that, for now at least, […]